Insider trading

Period: 120 months Stock: NTRA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

951 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

951 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

951 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

951 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
951 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
951 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

951 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Apr 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$7.27M 80,000 at 90.82
40.5%
Planned (10b5-1)
15 Apr 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$634.80K 6,816 at 93.13
2.9%
Planned (10b5-1)
3 Apr 2024
Sheena Jonathan Director
Sold on a plan 3×
$2.47M 26,700 at 92.47
7.7%
Planned (10b5-1)
2 Apr 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$127.63K 1,378 at 92.62
1.9%
Planned (10b5-1)
28 Mar 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$240.69K 2,662 at 90.42
1.1%
Planned (10b5-1)
28 Mar 2024
Sheena Jonathan Director · indirect
Sold on a plan 2×
$90.13K 1,000 at 90.13
1.4%
Planned (10b5-1)
28 Mar 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$82.64K 914 at 90.42
1.3%
Planned (10b5-1)
28 Mar 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$67.18K 743 at 90.42
0.4%
Planned (10b5-1)
28 Mar 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$63.92K 707 at 90.42
0.4%
Planned (10b5-1)
28 Mar 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$41.95K 464 at 90.42
0.4%
Planned (10b5-1)
28 Mar 2024
Sheena Jonathan Director
Sold on a plan 2×
$40.33K 447 at 90.22
0.1%
Planned (10b5-1)
15 Mar 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$7.40M 83,223 at 88.96
26.4%
Planned (10b5-1)
15 Mar 2024
Chapman Steven Leonard CEO AND PRESIDENT · indirect
Sold on a plan 3×
$4.53M 50,910 at 89.02
100%
Sold half or more
6 Mar 2024
Sheena Jonathan Director
Sold on a plan 2×
$443.49K 5,000 at 88.70
1.1%
Planned (10b5-1)
5 Mar 2024
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan 4×
$16.61M 190,000 at 87.40
18.1%
Planned (10b5-1)
5 Mar 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold at will
$824.09K 9,326 at 88.37
3.6%
Not planned
5 Mar 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold at will
$249.72K 2,826 at 88.37
3.8%
Not planned
5 Mar 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold at will 2×
$198.36K 2,245 at 88.36
1.1%
Not planned
5 Mar 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold at will
$190.87K 2,160 at 88.37
1.0%
Not planned
5 Mar 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold at will 2×
$162.40K 1,838 at 88.36
1.6%
Not planned
5 Mar 2024
Sheena Jonathan Director
Sold on a plan
$90.84K 1,028 at 88.37
0.2%
Planned (10b5-1)
5 Mar 2024
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 2×
$89.42K 1,012 at 88.36
0.1%
Planned (10b5-1)
29 Feb 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 4×
$1.83M 20,526 at 89.01
9.1%
Planned (10b5-1)
29 Feb 2024
Sheena Jonathan Director
Sold at will 4×
$863.43K 10,000 at 86.34
2.1%
Not planned
29 Feb 2024
Sheena Jonathan Director · indirect
Sold at will 2×
$540.11K 6,000 at 90.02
29.0%
Not planned
27 Feb 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$2.65M 35,307 at 75.09
14.7%
Planned (10b5-1)
16 Feb 2024
ROSENMAN HERM Director
Sold at will 2×
$6.51M 93,901 at 69.37
60.4%
Sold half or more
7 Feb 2024
Sheena Jonathan Director
Sold on a plan
$350.49K 5,000 at 70.10
1.0%
Planned (10b5-1)
7 Feb 2024
Sheena Jonathan Director · indirect
Sold on a plan 2×
$70.10K 1,000 at 70.10
5.4%
Planned (10b5-1)
6 Feb 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$2.38M 34,029 at 70.03
32.5%
Planned (10b5-1)
6 Feb 2024
Sheena Jonathan Director · indirect
Sold on a plan 2×
$420.01K 6,000 at 70.00
24.8%
Planned (10b5-1)
1 Feb 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold at will
$1.51M 22,281 at 67.73
24.0%
Not planned
29 Jan 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold at will
$964.19K 14,813 at 65.09
5.7%
Not planned
29 Jan 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold at will
$277.61K 4,265 at 65.09
2.0%
Not planned
29 Jan 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold at will
$223.00K 3,426 at 65.09
1.7%
Not planned
29 Jan 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold at will
$210.57K 3,235 at 65.09
3.4%
Not planned
29 Jan 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold at will
$153.48K 2,358 at 65.09
2.1%
Not planned
29 Jan 2024
Sheena Jonathan Director
Sold at will
$35.54K 546 at 65.09
0.1%
Not planned
24 Jan 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$63.25K 944 at 67.00
1.4%
Planned (10b5-1)
23 Jan 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$145.01K 2,202 at 65.86
3.2%
Planned (10b5-1)
22 Jan 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold at will
$133.46K 1,958 at 68.16
1.1%
Not planned
22 Jan 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold at will
$60.80K 892 at 68.16
0.5%
Not planned
22 Jan 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$52.55K 771 at 68.16
1.1%
Planned (10b5-1)
22 Jan 2024
Sheena Jonathan Director
Sold on a plan 2×
$23.92K 351 at 68.16
0.1%
Planned (10b5-1)
3 Jan 2024
Sheena Jonathan Director
Sold on a plan 2×
$301.50K 5,000 at 60.30
1.1%
Planned (10b5-1)
3 Jan 2024
Sheena Jonathan Director · indirect
Sold on a plan 3×
$60.45K 1,000 at 60.45
4.5%
Planned (10b5-1)
29 Dec 2023
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$85.77K 1,377 at 62.29
2.1%
Planned (10b5-1)
28 Dec 2023
Chapman Steven Leonard CEO AND PRESIDENT
Sold at will
$164.81K 2,604 at 63.29
1.5%
Not planned
28 Dec 2023
Sheena Jonathan Director · indirect
Sold on a plan 2×
$62.12K 1,000 at 62.12
4.4%
Planned (10b5-1)
28 Dec 2023
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$57.91K 915 at 63.29
1.4%
Planned (10b5-1)
Showing 401–450 of 951. ← Newer Page 9 of 20 Older →